PRINCETON, NJ -- (MARKET WIRE) -- September 19, 2006 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chief Executive Officer, and Al Altomari, Chief Operating Officer, are scheduled to present to the investment community at the UBS Global Life Sciences Conference.
